Category
Elagolix
CAS Number
834153-87-6
Alternate CAS Number
832720-36-2(Na salt);2390005-65-7 (HCl salt) ; 2254609-59-9 (K salt) ; 2390005-66-8 (TFA salt)
Molecular Formula
C32H30F5N3O5
Molecular Weight
631.6 g/mol
Synonym

4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid; (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoic acid; 4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]butanoic acid

Keywords
Pharmaceutical Standards
Fine Chemicals
Metabolites.
Impurities
Intermediates
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Elagolix is an oral medication used to treat pain associated with endometriosis. It is a gonadotropin-releasing hormone (GnRH) receptor antagonist that works by lowering estrogen levels in the body, which helps reduce symptoms like pelvic pain, painful periods, and pain during intercourse. It is sold under the brand name Orilissa and is typically prescribed in different doses depending on symptom severity and treatment duration. Because it lowers estrogen, side effects can include hot flashes, headaches, mood changes, and decreased bone mineral density with long-term use.